-31%

est. 2Y upside i

Series B

Rank

#2962

Sector

AgTech

Est. Liquidity

~5Y

Data Quality

Data: Low

Due to insufficient financial data (revenue, growth rate, valuation), quantitative analysis is highly uncertain.

Last updated: July 3, 2026

Bull (15%)+50%

If Nitricity secures major contracts with large agricultural firms and organic fertilizer demand accelerates, revenue could reach $15M. Exit at 20x forward revenue yields $300M, a 50% gain from entry.

Base (55%)0%

Gradual adoption of organic liquid fertilizer leads to $10M revenue. At 20x multiple, valuation stays at $200M, resulting in 0% return before dilution.

Bear (30%)-75%

Incumbents (Nutrien, Yara) or biological alternatives (Pivot Bio) capture market share, limiting Nitricity to $5M revenue. Exit multiple compresses to 10x, valuation falls to $50M, a 75% loss.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

4500%

Total funding of $90.1M represents 45% of the assumed $200M entry valuation, giving preferred stock a significant liquidation preference over common.

Dilution Risk

high

With 38 employees and only $50M Series B, additional fundraising within 2 years is likely; assumed 20% dilution.

Secondary Liquidity

none

No secondary market reported; private shares are illiquid.

Other 4 roles

View all 4 open roles at Nitricity

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Nitricity's data — designed to show you've done your homework.

  • 1

    How does Nitricity's cost structure compare to Haber-Bosch based fertilizer at scale?

  • 2

    What is the customer acquisition cost and sales cycle for offtake agreements?

  • 3

    Given the high preference stack, what is the path to liquidity for common stockholders?

Community

Valuation Sentiment

Our model estimates -31% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.